Meta-analysis: The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 9, 2016, Pages 1539-1545

  Zhao, Zhanwei ^a   Yin, Zifang ^b   Wang, Shiqi ^a   Wang, Juan ^a   Bai, Bing ^a   Qiu, Zhaoyan ^a   Zhao, Qingchuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Shaanxi Maternal and Child Health Hospital   (China)

Author keywords

chromoendoscopy; early gastric cancer; premalignant gastric lesions; white light endoscopy

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHROMOENDOSCOPY; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY CANCER; EMBASE; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; PRECANCER; PRIORITY JOURNAL; PUBLISHING; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; STOMACH LESION; SYSTEMATIC REVIEW; WHITE LIGHT ENDOSCOPY; EARLY CANCER DIAGNOSIS; GASTROSCOPY; PRECANCEROUS CONDITIONS; PROCEDURES; STOMACH NEOPLASMS;

COLORING AGENT;

COLORING AGENTS; EARLY DETECTION OF CANCER; GASTROSCOPY; HUMANS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 84988655787     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13313     Document Type: Article

References (51)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127 (12): 2893–917.
2. Leung WK, Wu MS, Kakugawa Y et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008; 9 (3): 279–87.
3. Du J, Zhu X, Xie C et al. Telomere length, genetic variants and gastric cancer risk in a Chinese population. Carcinogenesis 2015; 36: 963–70.
4. Shen ZL, Song KY, Ye YJ et al. Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in china and Korea. J Gastric Cancer 2015; 15 (1): 19–28.
5. Fang WL, Huang KH, Chen JH et al. Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients. World J. Surg. 2011; 35 (12): 2723–9.
6. Marano L, Boccardi V, Braccio B et al. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the “N” parameter-related survival: the monoinstitutional NodUs Italian study. World J. Surg. Oncol. 2015; 13 (1): 215.
7. Qiu MZ, Wang ZQ, Zhang DS et al. Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China. Ann. Surg. Oncol. 2011; 18 (7): 1869–76.
8. Lee JH, Kim JH, Rhee K et al. Undifferentiated early gastric cancer diagnosed as differentiated histology based on forceps biopsy. Pathol. Res. Pract. 2013; 209 (5): 314–8.
9. Peitz U, Malfertheiner P. Chromoendoscopy: from a research tool to clinical progress. Dig. Dis. 2002; 20 (2): 111–9.
10. Okabayashi T, Gotoda T, Kondo H et al. Usefulness of indigo carmine chromoendoscopy and endoscopic clipping for accurate preoperative assessment of proximal gastric cancer. Endoscopy 2000; 32 (10): S62.
11. Kida M, Kobayashi K, Saigenji K. Routine chromoendoscopy for gastrointestinal diseases: indications revised. Endoscopy 2003; 35 (7): 590–6.
12. Kawahara Y, Takenaka R, Okada H et al. Novel chromoendoscopic method using an acetic acid–indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig. Endosc. 2009; 21 (1): 14–9.
13. Dohi O, Yagi N, Wada T et al. Recognition of endoscopic diagnosis in differentiated-type early gastric cancer by flexible spectral imaging color enhancement with indigo carmine. Digestion 2012; 86 (2): 161–70.
14. Price AB. The Sydney system: histological division. J. Gastroenterol. Hepatol. 1991; 6 (3): 209–22.
15. Fenoglio-Preiser CM. Gastrointestinal Pathology: An Atlas and Text, 3rd ed. edn. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2008; 1296.
16. Nomura S, Ida K, Terao S et al. Endoscopic diagnosis of gastric mucosal atrophy: multicenter prospective study. Dig. Endosc. 2014; 26 (6): 709–19.
17. Li WQ, Zhang L, Ma JL et al. Association between genetic polymorphisms of DNA base excision repair genes and evolution of precancerous gastric lesions in a Chinese population. Carcinogenesis 2009; 30 (3): 500–5.
18. Asaka M, Sugiyama T, Nobuta A et al. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001; 6 (4): 294–9.
19. Ohyauchi M, Imatani A, Yonechi M et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54 (3): 330–5.
20. Chen XY, van Der Hulst RW, Shi Y et al. Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients. J. Clin. Pathol. 2001; 54 (5): 367–70.
21. Zaky AH, Watari J, Tanabe H et al. Clinicopathologic implications of genetic instability in intestinal-type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach. Am. J. Clin. Pathol. 2008; 129 (4): 613–21.
22. Sugimura T, Matsukura N, Sato S. Intestinal metaplasia of the stomach as a precancerous stage. IARC Sci. Publ. 1982; 39: 515–30.
23. ECP-EURONUT-Intestinal Metaplasia Study Group, UK Sub-Group. Family history of gastric disease: a risk factor for intestinal metaplasia – a gastric precancerous lesion. Eur. J. Cancer Prev. 1995; 4 (2): 201–3.
24. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52 (24): 6735–40.
25. Zhang J, Guo SB, Duan ZJ. Application of magnifying narrow-band imaging endoscopy for diagnosis of early gastric cancer and precancerous lesion. BMC Gastroenterol. 2011; 11: 135.
26. Wong KSL, Adler DG, Chand B et al. Chromoendoscopy. Gastrointest. Endosc. 2007; 66 (4): 639–49.
27. Taghavi SA, Membari ME, Eshraghian A et al. Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions. Can. J. Gastroenterol. 2009; 23 (2): 105–8.
28. Pohl J, May A, Rabenstein T et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus. Endoscopy 2007; 39 (7): 594–8.
29. Whiting P, Rutjes AW, Reitsma JB et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med. Res. Methodol. 2003; 3: 25.
30. Kono Y, Takenaka R, Kawahara Y et al. Chromoendoscopy of gastric adenoma using an acetic acid indigocarmine mixture. World J. Gastroenterol. 2014; 20 (17): 5092–7.
31. Lee BE, Kim GH, Park Do Y et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol. 2010; 10: 97.
32. Sakai Y, Eto R, Kasanuki J et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest. Endosc. 2008; 68 (4): 635–41.
33. Ojetti V, Persiani R, Nista EC et al. A case–control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients. Eur. Rev. Med. Pharmacol. Sci. 2007; 11 (5): 291–6.
34. Bahin FF, Jayanna M, Williams SJ et al. Efficacy of viscous budesonide slurry for prevention of esophageal stricture formation after complete endoscopic mucosal resection of short-segment Barrett's neoplasia. Endoscopy 2016; 48: 71–4.
35. Yajima H, Omura N, Takahashi N et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer. Int. Surg. 2015; 100 (1): 169–72.
36. Facciorusso A, Antonino M, Di Maso M et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc 2014; 6 (11): 555–63.
37. Kim JE, Shin CS, Lee YC et al. Beneficial effect of intravenous magnesium during endoscopic submucosal dissection for gastric neoplasm. Surg. Endosc. 2015; 29: 3795–802.
38. Zhang Q, Wang F, Chen ZY et al. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer 2015. [Epub ahead of print].
39. Mouzyka S, Fedoseeva A. Chromoendoscopy with hematoxylin in the classification of gastric lesions. Gastric Cancer 2008; 11 (1): 15–21; discussion 21-2.
40. Pittayanon R, Rerknimitr R. Role of digital chromoendoscopy and confocal laser endomicroscopy for gastric intestinal metaplasia and cancer surveillance. World J Gastrointest Endosc 2012; 4 (10): 472–8.
41. Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest. Endosc. 2009; 69 (6): 1021–8.
42. Trivedi PJ, Braden B. Indications, stains and techniques in chromoendoscopy. QJM 2013; 106 (2): 117–31.
43. Kobayashi Y, Hayashino Y, Jackson JL et al. Diagnostic performance of chromoendoscopy and narrow band imaging for colonic neoplasms: a meta-analysis. Colorectal Dis. 2012; 14 (1): 18–28.
44. Hiraku Y, Goto H, Kohno M et al. Metal-mediated oxidative DNA damage induced by methylene blue. Biochim. Biophys. Acta 2014; 1840 (9): 2776–82.
45. Sturmey RG, Wild CP, Hardie LJ. Removal of red light minimizes methylene blue-stimulated DNA damage in esophageal cells: implications for chromoendoscopy. Mutagenesis 2009; 24 (3): 253–8.
46. Olliver JR, Wild CP, Sahay P et al. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003; 362 (9381): 373–4.
47. Hardie LJ, Olliver JR, Wild CP et al. Chromoendoscopy with methylene blue and the risk of DNA damage. Gastroenterology 2004; 126 (2): 623; author reply 623-4.
48. Kiesslich R, Jung M, DiSario JA et al. Perspectives of chromo and magnifying endoscopy: how, how much, when, and whom should we stain? J. Clin. Gastroenterol. 2004; 38 (1): 7–13.
49. Dinis-Ribeiro M, Da Costa-Pereira A, Lopes C et al. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J. Gastroenterol. Hepatol. 2007; 22 (10): 1594–604.
50. Konijeti GG, Shrime MG, Ananthakrishnan AN et al. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest. Endosc. 2014; 79 (3): 455–65.
51. Subramanian V, Mannath J, Ragunath K et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment. Pharmacol. Ther. 2011; 33 (3): 304–12.